176 related articles for article (PubMed ID: 15185015)
21. Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection.
Kostianets O; Shyyan M; Antoniuk SV; Filonenko V; Kiyamova R
Biomarkers; 2017 Mar; 22(2):149-156. PubMed ID: 27775439
[TBL] [Abstract][Full Text] [Related]
22. Expression of activating transcription factor-2, serum response factor and cAMP/Ca response element binding protein in the adult rat brain following generalized seizures, nerve fibre lesion and ultraviolet irradiation.
Herdegen T; Blume A; Buschmann T; Georgakopoulos E; Winter C; Schmid W; Hsieh TF; Zimmermann M; Gass P
Neuroscience; 1997 Nov; 81(1):199-212. PubMed ID: 9300412
[TBL] [Abstract][Full Text] [Related]
23. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
Int J Cancer; 1984 Sep; 34(3):339-48. PubMed ID: 6090321
[TBL] [Abstract][Full Text] [Related]
24. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel DNA regulatory element in the rabbit surfactant protein B (SP-B) promoter that is a target for ATF/CREB and AP-1 transcription factors.
Berhane K; Boggaram V
Gene; 2001 May; 268(1-2):141-51. PubMed ID: 11368910
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA).
Lagarkova MA; Koroleva EP; Kuprash DV; Boitchenko VE; Kashkarova UA; Nedospasov SA; Shebzukhov YV
Immunol Lett; 2003 Jan; 85(1):71-4. PubMed ID: 12505200
[TBL] [Abstract][Full Text] [Related]
27. Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma.
Maesako Y; Uchiyama T; Ohno H
Cancer Sci; 2003 Sep; 94(9):774-81. PubMed ID: 12967475
[TBL] [Abstract][Full Text] [Related]
28. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
29. Analysis of African Burkitt's and high-grade B cell non-Burkitt's lymphoma for Epstein-Barr virus genomes using in situ hybridization.
Prevot S; Hamilton-Dutoit S; Audouin J; Walter P; Pallesen G; Diebold J
Br J Haematol; 1992 Jan; 80(1):27-32. PubMed ID: 1311194
[TBL] [Abstract][Full Text] [Related]
30. Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells.
Tomeczkowski J; Beilken A; Frick D; Wieland B; König A; Falk MH; Reiter A; Welte K; Sykora KW
Blood; 1995 Aug; 86(4):1469-80. PubMed ID: 7543307
[TBL] [Abstract][Full Text] [Related]
31. Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas.
Mori N; Ishikawa C; Senba M; Kimura M; Okano Y
Biochem Pharmacol; 2011 May; 81(9):1106-15. PubMed ID: 21371446
[TBL] [Abstract][Full Text] [Related]
32. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
[TBL] [Abstract][Full Text] [Related]
33. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
34. Genetic characterization of transactivation of the human T-cell leukemia virus type 1 promoter: Binding of Tax to Tax-responsive element 1 is mediated by the cyclic AMP-responsive members of the CREB/ATF family of transcription factors.
Bantignies F; Rousset R; Desbois C; Jalinot P
Mol Cell Biol; 1996 May; 16(5):2174-82. PubMed ID: 8628284
[TBL] [Abstract][Full Text] [Related]
35. AIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin.
Gaidano G; Contarini M; Pastore C; Saglio G; Matera L
Proc Soc Exp Biol Med; 1996 Nov; 213(2):196-205. PubMed ID: 8931665
[TBL] [Abstract][Full Text] [Related]
36. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
37. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
Billaud M; Rousset F; Calender A; Cordier M; Aubry JP; Laisse V; Lenoir GM
Blood; 1990 May; 75(9):1827-33. PubMed ID: 1691936
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
[TBL] [Abstract][Full Text] [Related]
39. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma.
Ogden CA; Pound JD; Batth BK; Owens S; Johannessen I; Wood K; Gregory CD
J Immunol; 2005 Mar; 174(5):3015-23. PubMed ID: 15728515
[TBL] [Abstract][Full Text] [Related]
40. Identification of tumor-associated autoantigens with SEREX.
Türeci O; Usener D; Schneider S; Sahin U
Methods Mol Med; 2005; 109():137-54. PubMed ID: 15585919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
